Erlotinib and anaemia Patient Reports February 11, 2012

Erlotinib Side Effects Report #6085154-6
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 10, 2009. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, hypotension. Erlotinib dosage: (100 MG, QD), ORAL. Patient recovered.

Erlotinib Side Effects Report #6125376-9
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Mar 02, 2009. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood calcium decreased, dehydration, hypophagia, hypotension, platelet count decreased. Erlotinib dosage: 100 MG QD, ORAL. Patient recovered.

Erlotinib Side Effects Report #5803938-3
Erlotinib side effect was reported by a Physician from SPAIN on June 18, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, gastrointestinal toxicity, malignant neoplasm progression, nausea , pancreatic carcinoma. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, LOPERAMIDA, EPOETIN BETA, NEUPOGEN, BUPRENORFINE HYDROCHLORIDE, METAMIZOL MAGNESIUM, FENTANILO, ENOXAPARIN. Patient was hospitalized. Patient died on 02/09/2008.

Erlotinib Side Effects Report #5136498-3
Erlotinib side effect was reported by a Physician from GERMANY on Oct 16, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, epistaxis, iatrogenic injury, lung injury, pleural effusion, pneumothorax. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, ASPIRIN, NEXIUM, SIMVAHEXAL, XANEF, UNAT, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5196227-4
Erlotinib side effect was reported by a Physician from GERMANY on Dec 07, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, dyspnoea, epistaxis, pancreatic carcinoma metastatic, pleural effusion, pneumothorax. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ASPIRIN, NEXIUM, SIMVAHEXAL, GEMCITABINE, XANEF, UNAT, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6060251-X
Erlotinib side effect was reported by a Physician from HONG KONG on Jan 16, 2009. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, cardiac arrest , fall , platelet count decreased, viral infection , white blood cell count decreased. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with GEMCITABINE, FAMOTIDINE, DIHYDROCODEINE COMPOUND, ZOPICLONE, FERROUS SULPHATE, CLINDAMYCIN HYDROCHLORIDE, HYDROCORTISONE ACETATE, ISOPHANE INSULIN. Patient was hospitalized. Patient died on 01/14/2009.

Erlotinib Side Effects Report #6121303-9
Erlotinib side effect was reported by a Physician from HONG KONG on Feb 27, 2009. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, cardiac arrest , fall , mouth haemorrhage, platelet count decreased, viral infection , white blood cell count decreased. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, FAMOTIDINE, DIHYDROCODEINE COMPOUND, ZOPICLONE, FERROUS SULPHATE, CLINDAMYCIN HYDROCHLORIDE, HYDROCORTISONE ACETATE. Patient was hospitalized. Patient died on 01/14/2009.

Erlotinib Side Effects Report #6112634-7
Erlotinib side effect was reported by a Health Professional from GERMANY on Feb 23, 2009. Female patient, 66 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, lymphangiosis carcinomatosa, pain . Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, HYDROMORPHONE, PANTOPRAZOL, DIPYRONE, METOCLOPRAMIDE, NOVALGIN. Patient was hospitalized. Patient died on 11/19/2008.

Erlotinib Side Effects Report #5772994-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 27, 2008. Female patient, 53 years of age, weighting 235.9 lb, was diagnosed with ovarian cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, blood chloride decreased, blood chloride increased, blood culture positive, cardiomegaly, cellulitis , confusional state, diarrhoea. Erlotinib dosage: 250 MG, DAYS 2-16/Q3W), ORAL. During the same period patient was treated with ALIMTA, XANAX, PERCOCET, DECADRON, MODUCAL, LIPITOR, AMBIEN, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5916941-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Female patient, 74 years of age, weighting 149.7 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, intra-abdominal haemorrhage, nausea , platelet count increased, prothrombin time prolonged. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, COUMADIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5688184-9
Erlotinib side effect was reported by a Physician from FRANCE on Mar 14, 2008. Female patient, 54 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: (150 MG, QD), ORAL : (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6075362-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 26, 2009. Male patient, 76 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, platelet count decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, INSULIN, EXELON, ASPIRIN, GLUCOTROL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5691881-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Male patient, 84 years of age, weighting 141.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, anorexia, back pain , constipation , failure to thrive, malignant neoplasm progression, rash , weight decreased. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, HYTRIN, ZOCOR, NEURONTIN, GEMFIBROZIL, NORTRIPTYLINE, GLYBURIDE AND METFORMIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5710611-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Female patient, 75 years of age, weighting 151.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anaemia, diarrhoea, diverticulum, dyspnoea, fatigue, gallbladder disorder, haematocrit decreased, haemoglobin decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, NORVASC, BENAZEPRIL, LEXAPRO, DETROL, CLARINEX, HYDROCHLOROTHIAZIDE, IRON POLYSACCHARIDE. Patient was hospitalized and became disabled. Patient recovered.


Erlotinib Side Effects Report #5719902-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 14, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess , anaemia, anorexia, asthenia, blood creatinine increased, blood pressure decreased, bronchial carcinoma, cardio-respiratory arrest, dehydration. Erlotinib dosage: (150 MG,QD),ORAL; 9100 MG, QD), ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.

Erlotinib Side Effects Report #5216889-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 02, 2007. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal perforation, haemorrhage, inappropriate antidiuretic hormone secretion, iron deficiency anaemia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, REGLAN, PROCRIT. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6140951-3
Erlotinib side effect was reported by a Physician from GREECE on Mar 17, 2009. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, infection , po2 decreased. Erlotinib dosage: (150 MG, QD DAYS 1 TO 12), ORAL. During the same period patient was treated with DOCETAXEL, MEDROL ACETATE, ZANTAC, CETIRIZINE, LANTUS, COAPROVEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6137700-1
Erlotinib side effect was reported by a Physician from FRANCE on Mar 13, 2009. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disease progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MORPHINE SULPHATE, KETOPROFEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5765547-4
Erlotinib side effect was reported by a Physician from HUNGARY on May 20, 2008. Male patient, 69 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, duodenal ulcer, erosive duodenitis, neoplasm progression, neutropenia, reflux oesophagitis, thrombocytopenia. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with PEMETREXED, SALBUTAMOL, TITROPIUM BROMIDE, FORMOTEROL, PERINDOPRIL ERBUMINE, FUROSEMIDE, FAMOTIDINE, FOLIC ACID. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5862118-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Aug 11, 2008. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, haematochezia, shock haemorrhagic. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LOXONIN, MUCOSAL, MUCODYNE. Patient died on 04/17/2008.

Erlotinib Side Effects Report #5900831-2
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 11, 2008. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, haematochezia, shock haemorrhagic. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LOXONIN, MUCOSAL, MUCODYNE. Patient died on 04/17/2008.

Erlotinib Side Effects Report #5328191-9
Erlotinib side effect was reported by a Physician from PHILIPPINES on Apr 27, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dizziness . Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4896286-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 66 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, bacteraemia, blood calcium decreased, blood sodium decreased, breath sounds abnormal, cardio-respiratory arrest, chest discomfort. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, ASPIRIN, LOVENOX, ADVAIR DISKUS, ALBUTEROL INHALER, MS CONTIN, PERCOCET, SIMETHICONE. Patient died on 11/01/2005.

Erlotinib Side Effects Report #6058146-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, fluid intake reduced, hypoxia, lethargy, malignant neoplasm progression, mobility decreased, pleural effusion, pneumonia . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with NYSTATIN, CITALOPRAM HYDROBROMIDE, LORAZEPAM, OXYCODONE. Patient was hospitalized. Patient died on 07/23/2008.


Erlotinib Side Effects Report #5775267-8
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on May 28, 2008. Male patient, 64 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, oral intake reduced, platelet count increased, white blood cell count increased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with METOCLOPRAMIDE, LOPERAMIDE, KYTRIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5794565-5
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on June 11, 2008. Male patient, 64 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, oral intake reduced. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with METOCLOPRAMIDE, LOPERAMIDE, KYTRIL, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6140651-X
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 16, 2009. Male patient, 64 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, hypophagia, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOCLOPRAMIDE, LOPERAMIDE, KYTRIL, STILNOX, ONDANSETRON, SMECTITE. Patient was hospitalized. Patient died on 05/22/2008.

Erlotinib Side Effects Report #5744906-X
Erlotinib side effect was reported by a Health Professional from PHILIPPINES on May 01, 2008. Male patient, 63 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5765510-3
Erlotinib side effect was reported by a Physician from PHILIPPINES on May 22, 2008. Male patient, 63 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.


Erlotinib Side Effects Report #5828487-8
Erlotinib side effect was reported by a Physician from PHILIPPINES on July 15, 2008. Male patient, 63 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.

Erlotinib Side Effects Report #5979005-5
Erlotinib side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Nov 14, 2008. Male patient, 63 years of age, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with LORATADINE, ALGIFEN, REASEC. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5145872-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Male patient, 61 years of age, weighting 125.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood creatine increased, blood glucose increased, blood potassium increased, blood sodium decreased, blood urea increased, coagulopathy, hypoperfusion, international normalised ratio decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with VELCADE, NEXIUM, LIPITOR, COLACE, ZESTRIL, DILANTIN, RANITIDINE, TEGRETOL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5194056-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 11, 2006. Male patient, 61 years of age, weighting 125.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blood bicarbonate increased, blood calcium decreased, blood creatinine increased, blood glucose increased, blood potassium increased, blood pressure systolic decreased, blood sodium decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with VELCADE, WARFARIN, NEXIUM, LIPITOR, COLACE, ZESTRIL, DILANTIN, RANITIDINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5747225-0
Erlotinib side effect was reported by a Health Professional from HUNGARY on May 08, 2008. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METHYLPREDNISOLONE, FAMOTIDINE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5832474-3
Erlotinib side effect was reported by a Physician from HUNGARY on July 16, 2008. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, lung neoplasm malignant, malignant neoplasm progression. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with METHYLPREDNISOLONE, FAMOTIDINE. Patient was hospitalized. Patient died on 05/06/2008.

Erlotinib Side Effects Report #5856728-X
Erlotinib side effect was reported by a Health Professional from HUNGARY on Aug 05, 2008. Female patient, 61 years of age, weighting 58.00 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with MTHYLPREDNISOLONE, FAMOTIDINE. Patient was hospitalized. Patient died on 05/06/2008.

Erlotinib Side Effects Report #5248071-7
Erlotinib side effect was reported by a Physician from BELGIUM on Feb 05, 2007. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5313450-6
Erlotinib side effect was reported by a Physician from PHILIPPINES on Apr 09, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5328165-8
Erlotinib side effect was reported by a Physician from BELGIUM on Apr 26, 2007. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bicarbonate increased, blood bilirubin increased, blood chloride decreased, blood potassium decreased, blood sodium decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with MEDROL, EMCONCOR, LANOXIN, SERETIDE, CORDARONE, DIAMICRON. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5186457-X
Erlotinib side effect was reported by a Physician from PHILIPPINES on Nov 28, 2006. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5196409-1
Erlotinib side effect was reported by a Physician from PHILIPPINES on Dec 11, 2006. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5840320-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 28, 2008. Male patient, 59 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, chest pain , cough, disease progression, hyperhidrosis, pyrexia, renal cyst, renal failure, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, LOPERAMIDE HYDROCHLORIDE, PAREGORIC, VITAMIN B6, IRON. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5506949-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, condition aggravated, dehydration, diarrhoea, lung cancer metastatic, pneumonia . Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5739357-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, dehydration, diarrhoea, metastases to lung, pneumonia , pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with HYDROCODONE, ACETAMINOPHEN, DIPHENHYDRAMINE, CEPHALEXIN, IBUPROFEN, LOPERAMIDE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5230793-5
Erlotinib side effect was reported by a Physician from PHILIPPINES on Jan 19, 2007. Female patient, 45 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5196405-4
Erlotinib side effect was reported by a Physician from PHILIPPINES on Dec 11, 2006. Female patient, 45 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, OXYCODONE, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5578125-7
Erlotinib side effect was reported by a Physician from NETHERLANDS on Dec 18, 2007. Female patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anxiety , haemoptysis, respiratory arrest. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with INDOMETHACIN, CLARITHROMYCIN, AUGMENTIN, DOPAMINE, ACTRAPID, MIDAZOLAM, HALOPERIDOL, MINRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5409385-0
Erlotinib side effect was reported by a Physician from PHILIPPINES on July 23, 2007. Female patient, 34 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, neutropenia, stomatitis, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5442907-2
Erlotinib side effect was reported by a Physician from PHILIPPINES on Aug 15, 2007. Female patient, 34 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, mucosal inflammation, neutropenia, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5562710-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 11, 2007. Female patient, weighting 140.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, enterocolitis infectious, gastroenteritis , lower gastrointestinal haemorrhage. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB, ETODOLAC, NAPROSYN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5143189-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 31, 2006. Male patient, 64 years of age, weighting 207.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, cancer pain, chest pain , gastrooesophageal reflux disease, musculoskeletal pain. Erlotinib dosage: 100MG, QD, PO. During the same period patient was treated with RAPAMUNE, VITAMIN B6, PRILOSEC, ACETAZOLAMIDE, UROCIT K, FOLIC ACID, ZANTAC, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5699457-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 07, 2008. Female patient, weighting 227.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , hyperglycaemia, hypertension, hypothyroidism, ileus, renal cancer metastatic, sepsis . Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with RAPAMUNE, METOPROLOL TARTRATE, NORVASC, SPIRONOLACTONE, POTASSIUM CHLORIDE, OXYCODONE, LEVOTHYROXINE. Patient died on 05/25/2007.

Erlotinib Side Effects Report #5567677-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Male patient, 80 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, fatigue, nausea . Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6093030-8
Erlotinib side effect was reported by a Physician from JAPAN on Feb 10, 2009. Female patient, 82 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood lactate dehydrogenase increased, haptoglobin increased, lung adenocarcinoma metastatic, metastases to bone marrow. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with RIZE, SELBEX, LANSOPRAZOLE, DIOVAN, BETAMETHASONE, AMOXAPINE. Patient was hospitalized. Patient died on 12/22/2008.

Erlotinib Side Effects Report #5779670-1
Erlotinib side effect was reported by a Physician from JAPAN on June 02, 2008. Female patient, 78 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with IRESSA, NIFEDIPINE, ONEALFA, MUCOSTA, FAMOTIDINE, DEPAS, LASIX, FIRSTCIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5875377-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Aug 21, 2008. Female patient, 78 years of age, weighting 99.21 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SPEAMIT, ONEALFA, MUCOSTA, GASTER D, DEPAS, LASIX, FIRSTCIN, LOXONIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5731802-7
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 22, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, haemoptysis, interstitial lung disease, pulmonary alveolar haemorrhage, pyrexia. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LANIRAPID, VERAPAMIL HYDROCHLORIDE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5935294-4
Erlotinib side effect was reported by a Physician from JAPAN on Oct 14, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, aspiration, interstitial lung disease, pulmonary alveolar haemorrhage, tumour haemorrhage. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LANIRAPID, VERAPAMIL HYDROCHLORIDE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6128091-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 05, 2009. Female patient, 72 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, pyrexia, rash . Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with CANDESARTAN CILEXETIL, NEUROTROPIN, TIZANIDINE, MESITAT, MICODYNE, TAGAMET, APLACE. Patient recovered.


Erlotinib Side Effects Report #5839451-7
Erlotinib side effect was reported by a Physician from JAPAN on July 24, 2008. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.

Erlotinib Side Effects Report #5891593-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 05, 2008. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, malignant neoplasm progression, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.

Erlotinib Side Effects Report #5935297-X
Erlotinib side effect was reported by a Physician from JAPAN on Oct 13, 2008. Female patient, 70 years of age, weighting 77.16 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, rash . Erlotinib dosage: (150 MG, QD), ORAL. Patient recovered.

Erlotinib Side Effects Report #6121204-6
Erlotinib side effect was reported by a Physician from JAPAN on Feb 27, 2009. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, malignant neoplasm progression, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.

Erlotinib Side Effects Report #5856881-8
Erlotinib side effect was reported by a Physician from JAPAN on Aug 07, 2008. Female patient, 67 years of age, weighting 80.25 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, malaise, rash . Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with ZANTAC, MUCOSTA, LOXONIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6088069-2
Erlotinib side effect was reported by a Physician from JAPAN on Feb 06, 2009. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastritis, haemorrhage, haemothorax, rash , urinary tract infection . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with GASTER D, TOCOPHEROL CONCENTRATE CAP, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5648134-8
Erlotinib side effect was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, constipation , dysgeusia, gastritis, hepatic function abnormal, lung disorder, pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MORPHINE, PRIMPERAN, CALCIUM LACTATE, GLYCYRON, ALFAROL, SUCRALFATE, PREDNISOLONE. Patient recovered.

Erlotinib Side Effects Report #5735802-2
Erlotinib side effect was reported by a Physician from JAPAN on Apr 09, 2008. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, dysgeusia, hepatic function abnormal, lung consolidation, malignant neoplasm progression, pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MORPHINE, PRIMPERAN, CALCIUM LACTATE, GLYCYRON, ALFAROL, SUCRALFATE, PREDNISOLONE. Patient died.

Erlotinib Side Effects Report #5731804-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 22, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, haemoptysis, haemorrhage. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MAGNESIUM OXIDE, MORPHINE, ROPION. Patient died on 03/31/2008.

Erlotinib Side Effects Report #5839446-3
Erlotinib side effect was reported by a Physician from JAPAN on Apr 22, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, haemoptysis, metastases to bone, rash , tumour haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ROPION, MAGNESIUM OXIDE, MORPHINE, MAXIPIME, MIDAZOLAM, CEFIPIME. Patient died on 03/31/2008.


Erlotinib Side Effects Report #5722246-2
Erlotinib side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, hyponatraemia, malignant neoplasm progression, oedema, rash , white blood cell count increased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with OMEPRA, DEPAS, NORVASC, ZOLPIDEM TARTRATE. Patient died on 03/31/2008.

Erlotinib Side Effects Report #6058144-7
Erlotinib side effect was reported by a Health Professional from JAPAN on Jan 13, 2009. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, diarrhoea, disease progression, hyponatraemia, lung adenocarcinoma, malnutrition, masked facies. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with OMEPRAZOLE, DEPAS, NORVASC, ZOLPIDEM TARTRATE. Patient died on 03/24/2008.

Erlotinib Side Effects Report #5698439-X
Erlotinib side effect was reported by a Physician from JAPAN on Mar 20, 2008. Female patient, 58 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, melaena, stress . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ZANTAC, LASIX, ALDACTONE, RIZE, DEPAS, ISOSORBIDE, GASMOTIN, AVELOX. Patient recovered.

Erlotinib Side Effects Report #6088095-3
Erlotinib side effect was reported by a Physician from JAPAN on Feb 05, 2009. Female patient, 58 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, depressed level of consciousness, diverticulum, duodenal ulcer, malignant neoplasm progression, melaena, metastases to bone, metastases to central nervous system. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with ZANTAC, LASIX, ALDACTONE, RIZE, DEPAS, ISOSORBIDE, GASMOTIN, AVELOX. Patient died on 12/12/2008.

Erlotinib Side Effects Report #5711262-2
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 01, 2008. Female patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, haematemesis, haemorrhage. Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QD), ORAL. During the same period patient was treated with FERRUM, LOXONIN, KELNAC, GLYCYRON, ZOLPIDEM TARTRATE, DICLOFENAC, ATARAX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5797881-6
Erlotinib side effect was reported by a Health Professional from JAPAN on June 12, 2008. Female patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FAMOTIDINE, LOXONIN, MAGLAX. Patient recovered.

Erlotinib Side Effects Report #5817461-3
Erlotinib side effect was reported by a Physician from JAPAN on June 30, 2008. Female patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, duodenal ulcer, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GASTER D, LOXONIN, MAGLAX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6051350-7
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Female patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, duodenal ulcer, lung adenocarcinoma, malignant neoplasm progression, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with LOXONIN, GASTER D, MAGLAX. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5677814-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 04, 2008. Male patient, 75 years of age, was diagnosed with hepatoblastoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood blister, fibrin d dimer increased, haematoma, mass, metastasis, prothrombin time prolonged, sarcoma. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with BEVACIZUMAB, LOVENOX, DEXAMETHASONE, GLIPIZIDE, SIMVASTATIN, NADOLOL, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5729532-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, 75 years of age, was diagnosed with hepatoblastoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood blister, brain natriuretic peptide increased, contusion, haematoma, haemorrhage, muscle mass, thrombocytopenia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, LOVENOX, DEXAMETHASONE, GLIPIZIDE, SIMVASTATIN, NADOLOL, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5856883-1
Erlotinib side effect was reported by a Physician from PHILIPPINES on Aug 07, 2008. Female patient, 36 years of age, was diagnosed with hepatic cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, DOLCET. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5744845-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 01, 2008. Female patient, 55 years of age, weighting 153.0 lb, was diagnosed with head and neck cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood chloride decreased, cellulitis , hypomagnesaemia, nausea , pain . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with CISPLATIN, SYMBAX, AMBIEN, ATIVAN, ROXICET, GLUCOVANCE, DILAUDID, FENTANYL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5764153-5
Erlotinib side effect was reported by a Physician from UNITED STATES on May 20, 2008. Female patient, 55 years of age, weighting 153.0 lb, was diagnosed with head and neck cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, cellulitis , feeding disorder, food intolerance, hypomagnesaemia, nausea , oral pain. Erlotinib dosage: (150 MG, QD) ORAL. During the same period patient was treated with CISPLATIN, SYMBAX, AMBIEN, ATIVAN, ROXICET, GLUCOVANCE, DILAUDID, FENTANYL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5612226-X
Erlotinib side effect was reported by a Physician from DENMARK on Jan 17, 2008. Female patient, 58 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abnormal clotting factor, alanine aminotransferase increased, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased. Erlotinib dosage: 150 MG. During the same period patient was treated with BEVACIZUMAB, CONTALGIN, MORPHINE, MEGACE, PANTOPRAZOLE, PRIMPERAN, IMODIUM, PREDNISOLONE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5528528-1
Erlotinib side effect was reported by a Physician from DENMARK on Nov 09, 2007. Female patient, 55 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood bilirubin increased, catheter related complication, coagulation factor vii level decreased, coagulation factor x level decreased, disease progression, disseminated intravascular coagulation, dyspepsia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, TENORMIN, ACETAMINOPHEN, WHOLE BLOOD, PREDNISONE, IMOZOP. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5277741-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, febrile neutropenia, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5305173-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, dehydration, febrile neutropenia, hypertension, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5351038-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 21, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, chest pain , dehydration, febrile neutropenia, hypertension, nausea . Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5231284-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2007. Male patient, 64 years of age, weighting 162.0 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, PHENERGAN, PERCOCET, PAXIL, ARANESP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5307862-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 06, 2007. Male patient, 64 years of age, weighting 162.0 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood potassium decreased, nausea . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with TOPOTECAN, PHENERGAN, PERCOCET, PAXIL, ARANESP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5163216-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2006. Male patient, 64 years of age, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, chest pain , electrocardiogram st segment abnormal, electrocardiogram t wave abnormal, heart rate increased, hypoventilation, myocardial ischaemia, oxygen saturation decreased, qrs axis abnormal. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with TOPOTECAN, LEVAQUIN, PAXIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5173239-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 20, 2006. Male patient, 64 years of age, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, angina pectoris, blood pressure decreased, chest pain , heart rate increased, hypoventilation, oxygen saturation decreased, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, LEVAQUIN, PAXIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5478808-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 14, 2007. Male patient, 60 years of age, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, peroneal nerve palsy. Erlotinib dosage: 5 MG,QD, ORAL. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, COUMADIN, INSULIN, ASPIRIN, PRINIVIL, METFORMIN, VITAMIN CAP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5607502-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2008. Male patient, 60 years of age, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: 5 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, COUMADIN, INSULIN, ASPIRIN, PRINIVIL, METFORMIN, VITAMIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4814847-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2005. Male patient, weighting 154.3 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, confusional state, dehydration, diarrhoea, failure to thrive, laboratory test interference, orthostatic hypotension. Erlotinib dosage: 100MG QD ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5125290-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Male patient, 67 years of age, weighting 163.8 lb, was diagnosed with carcinoid tumour and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, anorexia, asthenia, chest pain , confusional state, dehydration, diarrhoea, fatigue. Erlotinib dosage: unknown. During the same period patient was treated with GLYBURIDE, FERROUS SULPHATE, KEPPRA, LORTAB, SANDOSTATIN, ZOMETA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5652118-3
Erlotinib side effect was reported by a Physician from SPAIN on Feb 25, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal toxicity. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, LOPERAMIDE, EPOETIN BETA, NEUPOGEN, BUPERORFINE HYDROCHLORIDE, METAMIZOL MAGNESIUM, FENTANILO, ENOXAPARIN. Patient was hospitalized. Patient died on 02/09/2008.

Erlotinib Side Effects Report #5643837-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess , anaemia, anorexia, asthenia, blood creatinine increased, dehydration, dermal cyst, failure to thrive, gastrointestinal haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL, 100 MG, QD, ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.

Erlotinib Side Effects Report #5677827-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess , anaemia, anorexia, asthenia, blood creatine increased, blood urea increased, cardio-respiratory arrest, dehydration, dermal cyst. Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.

Erlotinib Side Effects Report #5187707-6
Erlotinib side effect was reported by a Physician from PHILIPPINES on Nov 27, 2006. Male patient, 71 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, TRAMADOL, VITAMINS NOS, METOCLOPRAMIDE, CO AMOXICLAV. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5196410-8
Erlotinib side effect was reported by a Physician from PHILIPPINES on Dec 11, 2006. Male patient, 71 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, fatigue, insomnia, neutrophil count increased, platelet count increased. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, TRAMADOL, METOCLOPRAMIDE, CO AMOXICLAV. Patient was hospitalized. Patient recovered.